ProfileGDS4718 / 1564387_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 13% 19% 10% 13% 10% 10% 17% 15% 15% 10% 12% 10% 14% 16% 23% 10% 10% 16% 11% 10% 17% 13% 11% 11% 13% 20% 15% 14% 13% 17% 14% 13% 15% 16% 18% 26% 13% 16% 13% 13% 10% 13% 11% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.912613
GSM549102patient 115, normal, homogenized [OPG study]4.1070719
GSM549104patient 119, normal, homogenized [OPG study]3.7622310
GSM549108patient 138, normal, homogenized [OPG study]3.9105613
GSM549119patient 077, normal, homogenized [OPG study]3.8003710
GSM549133patient 032, cancer, homogenized [OPG study]3.7604510
GSM549139patient 042, cancer, homogenized [OPG study]4.0224417
GSM549099patient 107, normal, homogenized [OPG study]3.9598315
GSM549109patient 139, normal, homogenized [OPG study]3.999915
GSM549110patient 046, normal, homogenized [OPG study]3.782810
GSM549114patient 063, normal, homogenized [OPG study]3.8261112
GSM549122patient 082, normal, homogenized [OPG study]3.7940410
GSM549134patient 033, cancer, homogenized [OPG study]3.907514
GSM549136patient 036, cancer, homogenized [OPG study]3.9533116
GSM549140patient 044, cancer, homogenized [OPG study]4.2075323
GSM549111patient 047, normal, homogenized [OPG study]3.7512710
GSM549113patient 057, normal, homogenized [OPG study]3.762710
GSM549132patient 031, cancer, homogenized [OPG study]3.9908416
GSM549137patient 038, cancer, homogenized [OPG study]3.8031811
GSM549142patient 047, cancer, homogenized [OPG study]3.8454910
GSM549100patient 110, normal, homogenized [OPG study]4.0256317
GSM549107patient 135, normal, homogenized [OPG study]3.8798413
GSM549115patient 068, normal, homogenized [OPG study]3.7826311
GSM549116patient 072, normal, homogenized [OPG study]3.8014311
GSM549120patient 078, normal, homogenized [OPG study]3.8968913
GSM549131patient 030, cancer, homogenized [OPG study]4.0892520
GSM549118patient 074, normal, homogenized [OPG study]3.9601615
GSM549129patient 027, cancer, homogenized [OPG study]3.9396214
GSM549123patient 088, normal, homogenized [OPG study]3.8966113
GSM549124patient 006, cancer, homogenized [OPG study]4.0942917
GSM549126patient 015, cancer, homogenized [OPG study]3.9219114
GSM549128patient 025, cancer, homogenized [OPG study]3.8799113
GSM549103patient 117, normal, homogenized [OPG study]4.0012515
GSM549117patient 073, normal, homogenized [OPG study]3.9792316
GSM549138patient 041, cancer, homogenized [OPG study]4.0361318
GSM549141patient 045, cancer, homogenized [OPG study]4.3050626
GSM549130patient 028, cancer, homogenized [OPG study]3.8919113
GSM549101patient 111, normal, homogenized [OPG study]3.9913216
GSM549105patient 128, normal, homogenized [OPG study]3.8806313
GSM549106patient 134, normal, homogenized [OPG study]3.8605213
GSM549112patient 048, normal, homogenized [OPG study]3.7957810
GSM549125patient 011, cancer, homogenized [OPG study]3.8861713
GSM549127patient 024, cancer, homogenized [OPG study]3.7773111
GSM549135patient 035, cancer, homogenized [OPG study]3.8429913